Array BioPharma Cash Flow Statement
View: Annual | Quarterly
| Jun 09 | Jun 08 | Jun 07 | |
|---|---|---|---|
| Net Operating Cash Flow | (92.9) | (45.7) | (44.5) |
| Net Investing Cash Flow | 29.0 | 50.7 | (50.7) |
| Net Financing Cash Flow | 40.7 | 40.8 | 90.3 |
| Net Change in Cash | (23.2) | 45.8 | (4.9) |
| Depreciation & Amortization | 6.6 | 6.1 | 6.4 |
| Capital Expenditures | (2.9) | -- | (7.1) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
